Christopher Fenimore
Senior Vice President and Chief Financial Officer
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Regeneron Pharmaceuticals, Inc. (REGN) | Executive Vice President, Finance and Chief Financial Officer6 | $725,000 | $6,985,364 |
| 2024 | Regeneron Pharmaceuticals, Inc. (REGN) | Executive Vice President, Finance and Chief Financial Officer | $660,000 | $6,268,252 |
Earnings-call appearances
-
Regeneron Pharmaceuticals, Inc. Q3 FY2025 Earnings Call2025-10-28
Regeneron Pharmaceuticals, Inc. (REGN)
-
Regeneron Pharmaceuticals, Inc. Q2 FY2025 Earnings Call2025-08-01
Regeneron Pharmaceuticals, Inc. (REGN)
-
Regeneron Pharmaceuticals, Inc. Q1 FY2024 Earnings Call2024-05-02
Regeneron Pharmaceuticals, Inc. (REGN)